Royalty Pharma plc·4

May 9, 5:15 PM ET

Lloyd George W. 4

4 · Royalty Pharma plc · Filed May 9, 2025

Insider Transaction Report

Form 4
Period: 2025-05-08
Lloyd George W.
EVP, Investments & CLO
Transactions
  • Award

    Class A Ordinary Shares

    2025-05-08+48,64648,646 total(indirect: By LLC)
Holdings
  • Class A Ordinary Shares

    (indirect: By IRA)
    273,960
  • Class A Ordinary Shares

    3,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    495,860
  • Class A Ordinary Shares

    (indirect: By LLC)
    220,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    52,000
  • Class A Ordinary Shares

    (indirect: By LLC)
    28,000
  • Class A Ordinary Shares

    (indirect: By Spouse)
    4,011.19
Footnotes (1)
  • [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Documents

1 file
  • 4
    wk-form4_1746825335.xmlPrimary

    FORM 4